PD-L1 knockdown dramatically reduced p-FOXO1A and p-FOXO3A, which was further dramatically reduced by combination with 4 μM lycopene, which also meant much more FOXO1A and FOXO3A with tumor-suppressing activities. The gene discussed is CD274; the disease is neoplasm.